bioRxiv Science⌕ Search

Biology subjects

Lyon, A.

Publications and source records attributed to Lyon, A..

5 recordsLinked to original sources

Gβγ engages PLCβ3 at multiple sites to reorient and facilitate its activation

Phospholipase C {beta} (PLC{beta}) enzymes are activated by heterotrimeric G protein subunits, increasing hydrolysis of phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2) at the plasma membrane. All four human PLC{beta} isoforms (PLC{beta}1-4) are activated by Gq, while PLC{beta}1-3 are activated to varying extents by G{beta}{gamma}. The binding sites for Gq on PLC{beta} are well-established and much has been learned about its mechanism of activation, but comparatively little is known about G{beta}{gamma}-dependent activation. In this work, we used cryo-electron microscopy (cryo-EM) single particle analysis (SPA), functional assays, and bioluminescence resonance energy transfer (BRET) to investigate how G{beta}{gamma} interacts with PLC{beta}3 in concert with activated Gq to regulate phospholipase activity. G{beta}{gamma} heterodimers bind multiple surfaces of PLC{beta}3 to promote activation but alone do not recruit the enzyme to the plasma membrane. Instead, G{beta}{gamma} facilitates activation by Gq, most likely by reorienting the phospholipase catalytic site at the membrane to maximize PI(4,5)P2 hydrolysis and downstream Ca2+ release. Cell-based functional assays demonstrate that G{beta}{gamma} is required for maximal PLC{beta}3 activation even when Gq heterotrimers are the sole source of G{beta}{gamma}. Together, these findings demonstrate that G{beta}{gamma} acts as a critical positive allosteric modulator that regularly acts in concert with Gq to activate PLC{beta}3 at the plasma membrane.

biochemistry↗

Context-dependent evolutionary dynamics toward bacterial survival during sequential antibiotic treatment

To overcome the antibiotic resistance problem, exploiting reproducible evolutionary tradeoffs is considered key for designing evolution-proof antibiotic therapies. Yet the predictability of resistance evolution has been viewed as limited, given the often idiosyncratic genetic trajectories observed in laboratory evolution experiments. To address this, we partially mimicked clinical antibiotic pharmacodynamics by imposing strong selection and evolved Escherichia coli under single or sequential antibiotic treatment. Under single-antibiotic selection, endpoint resistance, persistence, and tolerance phenotypes were reproducible, but populations evolving in parallel frequently followed divergent genetic trajectories. Remarkably, sequential antibiotic use redirected these divergent paths toward genotypic and phenotypic convergence, driven by extinction of resistance-conferring mutations when switching to the next effective antibiotic. Single-cell RNA sequencing demonstrated that evolved cultures contain cells occupying distinct metabolic niches and include more cells in states with lower translational activity and higher expression of toxin-antitoxin genes. These findings provide evolutionary insights to inform clinically effective antibiotic treatment strategies that employ sequential treatment.

microbiology↗

RhoA Allosterically Activates Phospholipase Cε via its EF Hands

Phospholipase C{varepsilon} (PLC{varepsilon}) cleaves phosphatidylinositol lipids to increase intracellular Ca2+ and activate protein kinase C (PKC) in response to stimulation of cell surface receptors. PLC{varepsilon} is activated via direct binding of small GTPases at the cytoplasmic leaflets of cellular membranes. In the cardiovascular system, the RhoA GTPase regulates PLC{varepsilon} to initiate a pathway that protects against ischemia/reperfusion injuries, but the underlying molecular mechanism is not known. We present here the cryo-electron microscopy (cryo-EM) reconstruction of RhoA bound to PLC{varepsilon}, showing that the G protein binds a unique insertion within the PLC{varepsilon} EF hands. Deletion of or mutations to this PLC{varepsilon} insertion decrease RhoA-dependent activation without impacting regulation by other G proteins. Together, our data support a model wherein RhoA binding to PLC{varepsilon} allosterically activates the lipase and increases its interactions with the membrane, resulting in maximum activity and cardiomyocyte survival.

biochemistry↗

Impaired glycolysis in aged endothelial cells is associated with reduced neovascularisation upon tissue ischemia

The vascular system experiences an age-associated decline in tissue perfusion and response to ischemic diseases. The factors driving this age-associated neovascularization decline remain unclear. While old endothelial cells (ECs) adopt a pro-angiogenic gene expression profile, we observed a stark reduction in the proliferative capacity of old ECs, while migratory capabilities remain intact. This is paralleled by a drastic decline in glycolytic capacity and ATP production, which likely act as limiting factors to neovascularization. These findings may provide new strategies to restore EC function in aging, thereby improving organ resilience and extending health- and lifespan.

molecular biology↗

CM1-driven assembly and activation of Yeast γ-Tubulin Small Complex underlies microtubule nucleation

Microtubule (MT) nucleation is regulated by the {gamma}-tubulin ring complex ({gamma}TuRC), conserved from yeast to humans. In Saccharomyces cerevisiae, {gamma}TuRC is composed of seven identical {gamma}-tubulin small complex ({gamma}TuSC) sub-assemblies which associate helically to template microtubule growth. {gamma}TuRC assembly provides a key point of regulation for the MT cytoskeleton. Here we combine cross-linking mass spectrometry (XL-MS), X-ray crystallography and cryo-EM structures of both monomeric and dimeric {gamma}TuSCs, and open and closed helical {gamma}TuRC assemblies in complex with Spc110p to elucidate the mechanisms of {gamma}TuRC assembly. {gamma}TuRC assembly is substantially aided by the evolutionarily conserved CM1 motif in Spc110p spanning a pair of adjacent {gamma}TuSCs. By providing the highest resolution and most complete views of any {gamma}TuSC assembly, our structures allow phosphorylation sites to be mapped, surprisingly suggesting that they are mostly inhibitory. A comparison of our structures with the CM1 binding site in the human {gamma}TuRC structure at the interface between GCP2 and GCP6 allows for the interpretation of significant structural changes arising from CM1 helix binding to metazoan {gamma}TuRC.

biochemistry↗